• Lead the strategic development and execution of reimbursement and health economics (HEOR) strategies for PolyNovo’s portfolio • Ensure that patients have timely access to NovoSorb technology by securing favorable coverage policies • Navigate the complexities of hospital value analysis committees (VACs), Medicare/Medicaid, and private payers • Develop and execute comprehensive market access launch plans for new products and line extensions • Monitor and influence coding, coverage, and payment policies (DRGs, CPT codes, HCPCS) relevant to dermal substitutes and synthetic skin grafts • Lead the development of the "Value Dossier" to articulate PolyNovo’s economic and clinical advantages over traditional biological scaffolds • Engage directly with key medical directors at national and regional payers to secure positive medical policy coverage • Support the field sales team by providing tools and messaging to navigate Hospital Value Analysis Committees (VACs) • Address reimbursement barriers by providing education to billing and coding departments • Collaborate with the Clinical Affairs team to identify gaps in data and develop "Real World Evidence" (RWE) that demonstrates long-term cost savings (e.g., reduced length of stay, fewer surgeries) • Manage the creation of budget impact models and cost-effectiveness analyses • Represent PolyNovo in industry trade associations (e.g., AdvaMed)